{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:52:21Z","timestamp":1784829141072,"version":"3.55.0"},"reference-count":42,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2018,12,31]]},"DOI":"10.5582\/bst.2018.01255","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T22:30:42Z","timestamp":1545949842000},"page":"595-604","source":"Crossref","is-referenced-by-count":24,"title":["Danzhi Jiangtang Capsule ameliorates kidney injury &lt;i&gt;via &lt;\/i&gt;inhibition of the JAK-STAT signaling pathway and increased antioxidant capacity in STZ-induced diabetic nephropathy rats"],"prefix":"10.5582","volume":"12","author":[{"given":"Min","family":"Sun","sequence":"first","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Bu","sequence":"additional","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Anhui University of TCM"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Gu","sequence":"additional","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Zhang","sequence":"additional","affiliation":[{"name":"Anhui Provincial Key Laboratory of R&D of Chinese Material Medica, School of Life Science, Anhui University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, the First Affiliated Hospital of Anhui University of TCM"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wada J, Makino. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 2013; 124:139-152.","DOI":"10.1042\/CS20120198"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008; 19:433-442.","DOI":"10.1681\/ASN.2007091048"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 2013; 124:139-152.","DOI":"10.1042\/CS20120198"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, Muros-de-Fuentes M, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF. Inflammatory cytokines in diabetic nephropathy. J Diabetes Res. 2015; 2015:948417","DOI":"10.1155\/2015\/948417"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Brosius FC 3rd, He JC. JAK inhibition and progressive kidney disease. Curr Opin Nephrol Hypertens. 2015; 24:88-95.","DOI":"10.1097\/MNH.0000000000000079"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Marrero MB, Banes-Berceli AK, Stern DM, Eaton DC. Role of the JAK\/STAT signaling pathway in diabetic nephropathy. Am J Physiol Renal Physiol. 2006; 290:F762-F768.","DOI":"10.1152\/ajprenal.00181.2005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Brosius FC, Tuttle KR, Kretzler M. JAK inhibition in the treatment of diabetic kidney disease. Diabetologia. 2016; 59:1624-1627.","DOI":"10.1007\/s00125-016-4021-5"},{"key":"8","unstructured":"8. Trengove MC, Ward AC. SOCS proteins in development and disease. Am J Clin Exp Immunol. 2013; 2:1-29."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Linossi EM, Babon JJ, Hilton DJ, Nicholson SE. Suppression of cytokine signaling: The SOCS perspective. Cytokine Growth Factor Rev. 2013; 24:241-248.","DOI":"10.1016\/j.cytogfr.2013.03.005"},{"key":"10","unstructured":"10. Fang ZH, Cheng SH, Wu Q. Effect of Danzhi Jiangtang Capsule on NF-\u03baB and urinary albumin excretion rate in early diabetic nephropathy patients. World Science &amp; Technology-Modernization of TCM and Materia Medica. 2013; 15:891-895. (in Chinese)"},{"key":"11","unstructured":"11. Liu SS, Li ZN, Xu CQ, Xiong YY, Fang ZH. Effects of Danzhi Jiangtang Capsule on serum levels of Tumor Necrosis Factor Alpha and Chemokine (C-X-C Motif) ligand 5 in diabetic rats. Journal of Anhui University of Chinese Medicine. 2014; 33:58-61. (in Chinese)"},{"key":"12","unstructured":"12. Bao TT, Yang C, Chu QG. Effects of Dangzhi Jiangtang Capsules on abdominal aortic ultrastructure, MCP-1 and resistin mRNA expression in diabetic rats. Chinese Traditional Patent Medicine. 2015; 37:1888-1892. (in Chinese)"},{"key":"13","unstructured":"13. Li ZN, Xiong YY, Li L, Fang ZH. Effects of Danzhi Jiangtang Capsule on CXCL9 and IL-8 in diabetic model rats. Chinese Journal of Information on TCM. 2014; 21:45-47. (in Chinese)"},{"key":"14","unstructured":"14. Xiong YY, Li ZN, Liu SS. The influence of Danzhi Jiangtang Capsule on the expression of NF-\u03baB in kidney tissue of diabetic rats. Global Journal of Endocrinology and Metabolism Studies. 2014; 34:6-10. (in Chinese)"},{"key":"15","unstructured":"15. Niu YF, Fang ah, Liu J, Shi GB. The clinical efficacy of Danhzi Jiangtang Capsule on elderly patients with early diabetic nephropathy. Modern Chinese Medicine. 2008; 10:36-38. (in Chinese)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sun M, Li Y, Bu WJ, Zhao J, Zhu J, Gu L, Zhang P, Fang Z. DJC suppresses Advanced Glycation End Products-Induced JAK-STAT signaling and ROS in mesangial cells. Evid Based Complement Alternat Med. 2017; 2017:2942830.","DOI":"10.1155\/2017\/2942830"},{"key":"17","unstructured":"17. Wang YZ, Jiang L, Han YQ, Zuo D, Xia LZ. UPLC fingerprint of Danzhi Jiangtang Capsule. Clinical Journal of Traditional Chinese Medicine. 2012; 24:1009-1011. (in Chinese)"},{"key":"18","unstructured":"18. Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ, Fu ZW. Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr. 2007; 16 Suppl 1:412-417."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Barutta F, Bruno G, Grimaldi S, Gruden G. Inflammation in diabetic nephropathy: Moving toward clinical biomarkers and targets for treatment. Endocrine. 2015; 48:730-742.","DOI":"10.1007\/s12020-014-0437-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Feigerlov\u00e1 E, Battaglia-Hsu SF. IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives. Cytokine Growth Factor Rev. 2017; 37:57-65.","DOI":"10.1016\/j.cytogfr.2017.03.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C, Muros de Fuentes M, Garc\u00eda-P\u00e9rez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011; 7:327-340.","DOI":"10.1038\/nrneph.2011.51"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989; 143:3949-3955.","DOI":"10.4049\/jimmunol.143.12.3949"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Omote K, Gohda T, Murakoshi M, Sasaki Y, Kazuno S, Fujimura T, Ishizaka M, Sonoda Y, Tomino Y. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Am J Physiol Renal Physiol. 2014; 306:F1335-F1347.","DOI":"10.1152\/ajprenal.00509.2013"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Awad AS, You H, Gao T, Cooper TK, Nedospasov SA, Vacher J, Wilkinson PF, Farrell FX, Brian Reeves W. Macrophage-derived tumor necrosis factor-\u03b1 mediates diabetic renal injury. Kidney Int. 2015; 88:722-733.","DOI":"10.1038\/ki.2015.162"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Navarro JF, Mora-Fern\u00e1ndez C. The role of TNF-alpha in diabetic nephropathy: Pathogenic and therapeutic implications. Cytokine Growth Factor Rev. 2006; 17:441-450.","DOI":"10.1016\/j.cytogfr.2006.09.011"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Moreno JA, Moreno S, Rubio-Navarro A, G\u00f3mez Guerrero C, Ortiz A, Egido J. Role of chemokines in proteinuric kidney disorders. Expert Rev Mol Med. 2014; 16:e3.","DOI":"10.1017\/erm.2014.3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Awad AS, Kinsey GR, Khutsishvili K, Gao T, Bolton WK, Okusa MD. Monocyte\/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol Renal Physiol. 2011; 301:F1358-F1366.","DOI":"10.1152\/ajprenal.00332.2011"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Berthier CC, Zhang H, Schin M, <i>et al<\/i>. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes. 2009; 58:469-477.","DOI":"10.2337\/db08-1328"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, Chin YE, Yan H, Dworkin LD, Zhuang S. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010; 78:257-268.","DOI":"10.1038\/ki.2010.154"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wang X, Shaw S, Amiri F, Eaton DC, Marrero MB. Inhibition of the Jak\/STAT signaling pathway prevents the high glucose-induced increase in TGF-beta and fibronectin synthesis in mesangial cells. Diabetes. 2002; 51:3505-3509.","DOI":"10.2337\/diabetes.51.12.3505"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shi Y, Zhang Y, Wang C, Du C, Zhao S, Qi Z, Zhang Q, Duan H. Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-beta1 and fibronectin synthesis in human mesangial cells. FEBS Lett. 2008; 582:3484-3488.","DOI":"10.1016\/j.febslet.2008.09.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Liu Q, Xing L, Wang L, Yao F, Liu S, Hao J, Liu W, Duan H. Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy. J Histochem Cytochem. 2014; 62:119-128.","DOI":"10.1369\/0022155413512493"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zhou Y, Lv C, Wu C, Chen F, Shao Y, Wang Q. Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy. Acta Histochem. 2014; 116:981-988.","DOI":"10.1016\/j.acthis.2014.04.002"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ortiz-Mu\u00f1oz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, Sanz A, Blanco J, Mezzano S, Ortiz A, Egido J, Gomez-Guerrero C. Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol. 2010; 21:763-772.","DOI":"10.1681\/ASN.2009060625"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lu TC, Wang ZH, Feng X, Chuang PY, Fang W, Shen Y, Levy DE, Xiong H, Chen N, He JC. Knockdown of Stat3 activity <i>in vivo<\/i> prevents diabetic glomerulopathy. Kidney Int. 2009; 76:63-71.","DOI":"10.1038\/ki.2009.98"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107:1058-1070.","DOI":"10.1161\/CIRCRESAHA.110.223545"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011; 11:330-336.","DOI":"10.1007\/s11892-011-0196-9"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: The role of reducing oxidative stress in its protective property. Diabetes Res Clin Pract. 2009; 83:176-182.","DOI":"10.1016\/j.diabres.2008.10.007"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998; 275 (6 Pt 1):C1640-C1652.","DOI":"10.1152\/ajpcell.1998.275.6.C1640"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Duh\u00e9 RJ. Redox regulation of Janus kinase: The elephant in the room. JAKSTAT. 2013; 2:e26141.","DOI":"10.4161\/jkst.26141"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK\/STAT signaling and cytokine induction. Circ Res. 2000; 87:1195-1201.","DOI":"10.1161\/01.RES.87.12.1195"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 2003; 14(8 Suppl 3):S241-S245.","DOI":"10.1097\/01.ASN.0000077410.66390.0F"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/12\/6\/12_2018.01255\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:40:50Z","timestamp":1694526050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/12\/6\/12_2018.01255\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2018.01255","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}